Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging

Ali Pirasteh, Haley R. Clark, Endel A. Sorra, Ivan Pedrosa, Takeshi Yokoo

Research output: Contribution to journalArticle

Abstract

Purpose: To investigate the effect of steatosis on liver signal and enhancement in multiphasic contrast-enhanced (MCE) MRI. Materials and methods: In this IRB-approved, HIPAA-compliant, retrospective, observational study, 1217 MCE abdominal MRIs performed during 2014 at a single institution were reviewed. Of these, 1085 were excluded, due to potential factors other than steatosis that may affect liver signal intensity and/or enhancement. In the remaining 132, liver fat fraction (FF) was calculated from the in- and opposed-phase 2D T1-weighted images. Liver signal intensity, absolute enhancement, and relative enhancement on fat-suppressed (Dixon method) 3D T1-weighted images before and after injection of gadobutrol (arterial, portal venous, and equilibrium phases) were plotted against co-localized FF values and the linear trend was evaluated by Pearson correlation coefficient (r). P values

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalAbdominal Radiology
DOIs
StateAccepted/In press - Apr 23 2016

Fingerprint

Fatty Liver
Fats
Magnetic Resonance Imaging
Liver
Health Insurance Portability and Accountability Act
Research Ethics Committees
Observational Studies
Retrospective Studies
Injections

Keywords

  • Contrast media
  • Fatty liver
  • Gadolinium
  • Liver steatosis
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology
  • Radiological and Ultrasound Technology

Cite this

Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging. / Pirasteh, Ali; Clark, Haley R.; Sorra, Endel A.; Pedrosa, Ivan; Yokoo, Takeshi.

In: Abdominal Radiology, 23.04.2016, p. 1-7.

Research output: Contribution to journalArticle

@article{2640d623e066418d93da06f5353b58e9,
title = "Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging",
abstract = "Purpose: To investigate the effect of steatosis on liver signal and enhancement in multiphasic contrast-enhanced (MCE) MRI. Materials and methods: In this IRB-approved, HIPAA-compliant, retrospective, observational study, 1217 MCE abdominal MRIs performed during 2014 at a single institution were reviewed. Of these, 1085 were excluded, due to potential factors other than steatosis that may affect liver signal intensity and/or enhancement. In the remaining 132, liver fat fraction (FF) was calculated from the in- and opposed-phase 2D T1-weighted images. Liver signal intensity, absolute enhancement, and relative enhancement on fat-suppressed (Dixon method) 3D T1-weighted images before and after injection of gadobutrol (arterial, portal venous, and equilibrium phases) were plotted against co-localized FF values and the linear trend was evaluated by Pearson correlation coefficient (r). P values",
keywords = "Contrast media, Fatty liver, Gadolinium, Liver steatosis, Magnetic resonance imaging",
author = "Ali Pirasteh and Clark, {Haley R.} and Sorra, {Endel A.} and Ivan Pedrosa and Takeshi Yokoo",
year = "2016",
month = "4",
day = "23",
doi = "10.1007/s00261-016-0736-5",
language = "English (US)",
pages = "1--7",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",

}

TY - JOUR

T1 - Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging

AU - Pirasteh, Ali

AU - Clark, Haley R.

AU - Sorra, Endel A.

AU - Pedrosa, Ivan

AU - Yokoo, Takeshi

PY - 2016/4/23

Y1 - 2016/4/23

N2 - Purpose: To investigate the effect of steatosis on liver signal and enhancement in multiphasic contrast-enhanced (MCE) MRI. Materials and methods: In this IRB-approved, HIPAA-compliant, retrospective, observational study, 1217 MCE abdominal MRIs performed during 2014 at a single institution were reviewed. Of these, 1085 were excluded, due to potential factors other than steatosis that may affect liver signal intensity and/or enhancement. In the remaining 132, liver fat fraction (FF) was calculated from the in- and opposed-phase 2D T1-weighted images. Liver signal intensity, absolute enhancement, and relative enhancement on fat-suppressed (Dixon method) 3D T1-weighted images before and after injection of gadobutrol (arterial, portal venous, and equilibrium phases) were plotted against co-localized FF values and the linear trend was evaluated by Pearson correlation coefficient (r). P values

AB - Purpose: To investigate the effect of steatosis on liver signal and enhancement in multiphasic contrast-enhanced (MCE) MRI. Materials and methods: In this IRB-approved, HIPAA-compliant, retrospective, observational study, 1217 MCE abdominal MRIs performed during 2014 at a single institution were reviewed. Of these, 1085 were excluded, due to potential factors other than steatosis that may affect liver signal intensity and/or enhancement. In the remaining 132, liver fat fraction (FF) was calculated from the in- and opposed-phase 2D T1-weighted images. Liver signal intensity, absolute enhancement, and relative enhancement on fat-suppressed (Dixon method) 3D T1-weighted images before and after injection of gadobutrol (arterial, portal venous, and equilibrium phases) were plotted against co-localized FF values and the linear trend was evaluated by Pearson correlation coefficient (r). P values

KW - Contrast media

KW - Fatty liver

KW - Gadolinium

KW - Liver steatosis

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=84964240986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964240986&partnerID=8YFLogxK

U2 - 10.1007/s00261-016-0736-5

DO - 10.1007/s00261-016-0736-5

M3 - Article

C2 - 27108126

AN - SCOPUS:84964240986

SP - 1

EP - 7

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

ER -